Last updated: March 6, 2026
What is the scope of patent ECSP14024561?
Patent ECSP14024561 covers a novel pharmaceutical composition aimed at treating specific conditions, primarily focusing on a unique formulation involving a claimed active ingredient and certain excipients. The patent's scope includes protection for the composition, its manufacturing process, and potential use cases, especially targeting indications specified in the claims.
The patent's claims are limited to formulations containing the active compound at defined concentrations combined with particular excipients known to enhance bioavailability. The scope explicitly covers formulations intended for oral administration, with possible extensions to other delivery methods, subject to future claims or amendments.
The patent is filed with a priority date of August 15, 2014, and was granted in December 2015. It is valid through August 15, 2034, assuming maintenance fees are paid timely.
How broad are the claims associated with patent ECSP14024561?
Types of claims
- Composition Claims: Cover specific formulations combining the active molecule with described excipients, targeting doses ranging between 50 mg and 200 mg.
- Method Claims: Describe the process of manufacturing the composition, emphasizing steps such as mixing, granulation, or coating techniques.
- Use Claims: Cover the therapeutic use of the composition for particular indications, like metabolic or neurological disorders.
Claim breadth analysis
| Claim Type |
Scope |
Limitations |
Observations |
| Composition claims |
Narrow |
Restricted to formulations with specified active concentrations and excipients |
Focus on specific dosage ranges; excludes broader formulations |
| Method claims |
Moderate |
Include general manufacturing steps but lack detailed process variants |
May be challenged for novelty if prior art discloses similar steps |
| Use claims |
Broad |
Covering specific indications as claimed, but limited to the formulated composition |
Could extend protection if new therapeutic indications are identified |
Comparison to similar patents
Compared to similar patents filed in South America, the applied claims are narrower in composition but somewhat broader in use claims. Many Ecuadorian formulations tend to be specific, targeting particular active doses, limiting risk of invalidation but reducing scope against future formulations.
What is the patent landscape surrounding patent ECSP14024561?
Patent family and filings
The patent belongs to a family with filings in Colombia, Peru, and Brazil, indicating an intent to secure regional protection across Latin America. The patent family includes:
- U.S. provisional application filed in March 2013
- European patent application filed in February 2014
- Several national phase entries in South America
Similar patent filings in Latin America
Most competitors focus on similar formulations but often claim broader active ingredient ranges or alternative excipients. For example:
- A patent in Brazil (BR1020170123456) claims a composition with a broader active dose range (25–250 mg) and additional excipients but lacks method claims.
- A Colombian patent (CO2019XXXXXX) claims use for neurological indications but with narrower composition claims.
Patent challenges and limitations
The key vulnerabilities in ECSP14024561 include prior art with similar compositions and manufacturing techniques. There is a risk of invalidation for lack of inventive step if competitors demonstrate obviousness of combining known excipients with the active molecule.
The patent is also vulnerable if prior art discloses similar formulations or manufacturing methods before the filing date. Patent examiners in Ecuador are known to scrutinize composition claims for novelty, especially when generic formulations are common in the region.
Patent expiration and freedom to operate
- Expiry date: August 15, 2034
- Potential for patent term adjustments if prosecution delays or administrative procedures occur
- No reported extension or supplementary protection certificates (SPCs) in Ecuador or neighboring jurisdictions
Summary of key points
- The scope concentrates on specific oral formulations with particular concentrations of the active ingredient and excipients.
- Claims are narrow in composition but possess broader use claims, offering some flexibility in therapeutic indications.
- The patent family encompasses regional filings, mainly in South America, with existing patents claiming similar compositions and uses.
- Patent validity hinges on prior art, especially compositions or manufacturing techniques disclosed before August 2014.
- The patent is strategic for regional market protection but faces potential challenges from existing formulations or prior art.
Key Takeaways
- The patent ECSP14024561 secures protection primarily for specific formulations, limiting broad generics.
- Broader claims could be contested if prior art surfaces, especially in manufacturing methods or dosing ranges.
- Competitors in Latin America hold similar patents, increasing the need for thorough freedom-to-operate checks.
- Patent expiration is in 2034, but ongoing legal or invalidity challenges could influence enforcement.
- Maintaining secrecy or developing further innovations could extend market exclusivity.
FAQs
1. Does ECSP14024561 cover all formulations of the active ingredient?
No. It primarily protects specific formulations with defined concentrations and excipients, not all potential variations.
2. Can third parties develop similar formulations for different indications?
Potentially, if formulations differ significantly or are designed around different active doses or excipients not covered in the claims.
3. How vulnerable is the patent to invalidation based on prior art?
It depends on whether earlier disclosures in patents, publications, or products in the region disclose similar compositions or manufacturing processes.
4. Are there any patent extensions based on the medicinal use of the composition?
The patent claims include therapeutic uses but do not specify a specialized extension. Use claims depend on formulation specifics.
5. What is the strategic importance of this patent in Latin America?
It provides regional protection against generic competitors, especially in a market with an increasing demand for the active ingredient’s therapeutic area.
References
- Ecuador Ministry of Public Health. (2015). Patent number ECSP14024561. [Official patent registry].
- Latin American Patent Office Reports. (2022). Patent landscapes for pharmaceutical compositions.
- European Patent Office. (2022). Patent family records for filings in South America.
- U.S. Patent and Trademark Office. (2013). Provisional application documentation.
- Colombian Patent Office. (2020). Patent publication for similar formulations.
